Eradication of infectious diseases
|This article is outdated. (May 2014)|
Eradication is the reduction of an infectious disease's prevalence in the global host population to zero. It is sometimes confused with elimination, which describes either the reduction of an infectious disease's prevalence in a regional population to zero, or the reduction of the global prevalence to a negligible amount. Further confusion arises from the use of the term eradication to refer to the total removal of a given pathogen from an individual (also known as clearance of an infection), particularly in the context of HIV and certain other viruses where such cures are sought.
Selection of infectious diseases for eradication is based on rigorous criteria, as both biological and technical features determine whether a pathogenic organism is (at least potentially) eradicable. The targeted organism must not have a non-human reservoir (or, in the case of animal diseases, the infection reservoir must be an easily identifiable species, as in the case of rinderpest), and/or amplify in the environment. This implies that sufficient information on the life cycle and transmission dynamics is available at the time an eradication initiative is programmed. An efficient and practical intervention (e.g., a vaccine or antibiotic) must be available to interrupt transmission of the infective agent. Studies of measles in the pre-vaccination era led to the concept of the Critical community size, the size of the population below which a pathogen ceases to circulate. Use of vaccination programmes before the introduction of an eradication campaign can reduce the susceptible population. The disease to be eradicated should be clearly identifiable, and an accurate diagnostic tool should exist. Economic considerations, as well as societal and political support and commitment, are other crucial factors that determine eradication feasibility.
Eight attempts have been made to date to eradicate infectious diseases: two successful programs targeting smallpox and rinderpest; four ongoing programs targeting poliomyelitis, yaws, dracunculiasis and malaria; and two former programs targeting hookworm and yellow fever. Five more infectious diseases have been identified as of April 2008 as potentially eradicable with current technology by the Carter Center International Task Force for Disease Eradication—measles, mumps, rubella, lymphatic filariasis and cysticercosis.
- 1 Eradicated
- 2 Global eradication underway
- 3 Regional elimination established or under way
- 4 Other eradicable diseases
- 5 In fiction
- 6 See also
- 7 References
- 8 External links
So far, two diseases have been successfully eradicated—one specifically affecting humans (smallpox), and one affecting a wide range of ruminants (rinderpest).
Smallpox was the first disease, and so far the only infectious disease of humans, to be eradicated by deliberate intervention. It became the first disease for which there was an effective vaccine in 1798 when Edward Jenner showed the protective effect of inoculation (vaccination) of humans with material from cowpox lesions.
Smallpox (variola) occurred in two clinical varieties: variola major, with a mortality rate of up to 40 percent and variola minor, also known as alastrim, with a mortality rate less than 1 percent. The last naturally occurring case of Variola major was diagnosed in October 1975 in Bangladesh, and the last naturally occurring case of variola minor was diagnosed in October 1977 in Somalia. After two years' detailed analysis of national records the global eradication of smallpox was certified by an international commission of smallpox clinicians and medical scientists on December 9, 1979, and endorsed by the General Assembly of the World Health Organization on May 8, 1980. However the stock stored by US and Russia is still a concern as any accidental or deliberate release could create a new epidemic for persons born after or in the late 1980's, as they would largely lack vaccination against the smallpox virus. In 1986, the World Health Organization first recommended destruction of the virus, and later set the date of destruction to be 30 December 1993. This was postponed to 30 June 1999. Due to resistance from the U.S. and Russia, in 2002 the World Health Assembly agreed to permit the temporary retention of the virus stocks for specific research purposes. Destroying existing stocks would reduce the risk involved with ongoing smallpox research; the stocks are not needed to respond to a smallpox outbreak. Some scientists have argued that the stocks may be useful in developing new vaccines, antiviral drugs, and diagnostic tests; however, a 2010 review by a team of public health experts appointed by the World Health Organization concluded that no essential public health purpose is served by the U.S. and Russia continuing to retain virus stocks. The latter view is frequently supported in the scientific community, particularly among veterans of the WHO Smallpox Eradication Program. In March 2004 smallpox scabs were found tucked inside an envelope in a book on Civil War medicine in Santa Fe, New Mexico. The envelope was labeled as containing scabs from a vaccination and gave scientists at the Centers for Disease Control and Prevention an opportunity to study the history of smallpox vaccination in the U.S.
In July 2014 several vials of smallpox were discovered in an FDA laboratory at the National Institutes of Health location in Bethesda, Maryland.
During the 20th century, there were a series of campaigns to eradicate rinderpest, a viral disease which infected cattle and other ruminants and belonged to the same family as measles, primarily through the use of a live attenuated vaccine. The final, successful campaign was led by the Food and Agriculture Organization (FAO) of the United Nations. On 14 October 2010, with no diagnoses for nine years, the FAO announced that the disease had been completely eradicated, making this the first (and so far the only) disease of livestock to have been eradicated by human undertakings.
Global eradication underway
|International Wild Poliovirus Cases by Year|
A dramatic reduction of the incidence of poliomyelitis in industrialized countries followed the development of a vaccine in the 1950s. In 1960, Czechoslovakia became the first country certified to have eliminated polio.
In 1988, the World Health Organization (WHO), Rotary International, the United Nations Children's Fund (UNICEF), and the U.S. Centers for Disease Control and Prevention (CDC) passed the Global Polio Eradication Initiative. Its goal was to eradicate polio by the year 2000. The updated strategic plan for 2004–2008 expects to achieve global eradication by interrupting poliovirus transmission, using the strategies of routine immunization, supplementary immunization campaigns, and surveillance of possible outbreaks. The WHO estimates that global savings from eradication, due to forgone treatment and disability costs, could exceed one billion U.S. dollars per year.
The following world regions have been declared polio-free:
- The Americas (1994)
- Indo-West Pacific region (1997)
- Europe (1998)
- Western Pacific region, including China (2000)
- Southeast Asia region (2014), including India
The lowest annual polio prevalence seen so far was in 2012, with 223 reported cases. However, during the previous decade, following interruption of vaccination in Nigeria in 2003–4 and a reduction in immunisation in India in 2001–2, there was a resurgence of polio transmission: in 2001 there were 483 reported cases, but in the period of 2002 to 2010, the number of global reported cases remained between 750 and 2000 per year, with 1,349 cases in 2010. Some of these cases were the result of new importations in 31 countries which had previously interrupted transmission, leading to many subsequent outbreaks. Three further countries remain in which poliovirus transmission has never been interrupted (Nigeria, Pakistan, and Afghanistan). India was removed from the WHO list of polio-endemic countries in 2012 after no new cases were reported for one year. The 223 cases in 2012 were from 5 countries (122 in Nigeria; 58 in Pakistan; 37 in Afghanistan; 5 in Chad and 1 in Niger), compared to 650 cases from 16 countries for 2011.
|International Guinea Worm Cases by Year |
Dracunculiasis, also called guinea worm disease, is a painful and disabling parasitic disease caused by a worm, Dracunculus medinensis. It is spread through consumption of drinking water infested with copepods hosting Dracunculus larvae. The Carter Center has led the effort to eradicate the disease, along with the CDC, the WHO, UNICEF, and the Bill and Melinda Gates Foundation.
Unlike diseases such as smallpox and polio, there is no vaccine or drug therapy for guinea worm. Eradication efforts have been based on making drinking water supplies safer (e.g. by provision of borehole wells, or through treating the water with larvicide), on containment of infection and on education for safe drinking water practices. These strategies have produced many successes: two decades of eradication efforts have reduced guinea worm's global incidence to 148 cases in 2013, down from an estimated 3.5 million in 1986. Success has been slower than was hoped—the original goal for eradication was 1995. The WHO has certified 180 countries free of the disease, and only five countries — South Sudan, Mali, Ethiopia, Chad, and Sudan— reported cases of guinea worm in 2013. The disease is not endemic in Sudan. Seventy-six percent of all cases reported in 2013 were in South Sudan. As of 2010, the WHO predicted it would be "a few years yet" before eradication is achieved, on the basis that it took 6–12 years for the countries that have so far eliminated guinea worm transmission to do so after reporting a similar number of cases to that reported by Sudan in 2009. Up to the end of August 2014, cases have dropped 34% compared to the same period of 2013 with only South Sudan and Chad reporting more than 2 cases - 68 and 9 respectively. The last reported uncontained case outside of South Sudan and Chad was in October 2013.
Yaws is a rarely fatal but highly disfiguring disease caused by the spiral-shaped bacterium (spirochete) Treponema pallidum pertenue, a relative of the syphilis bacteria Treponema pallidum pallidum, spread through skin to skin contact with infectious lesions. The global prevalence of this disease and the other endemic treponematoses, bejel and pinta, was reduced by the Global Control of Treponematoses (TCP) programme between 1952 and 1964 from about 50 million cases to about 2.5 million (a 95% reduction). However, following the cessation of this program these diseases remained at a low prevalence in parts of Asia, Africa and the Americas with sporadic outbreaks. According to the new official WHO roadmap, the elimination should be achieved by 2020. Yaws is currently targeted by the South-East Asian Regional Office of the WHO for elimination from the remaining endemic countries in this region (India, Indonesia and East Timor) by 2010, and so far, this appears to have met with some success, since no cases have been seen in India since 2004. The discovery that oral antibiotic azithromycin can be used instead of the previous standard, injected penicillin, is currently being field tested for a mass campaign. The campaign was in an early stage in 2013, still gathering data on disease incidence and planning initial large-scale treatment campaigns in Cameroon, Ghana, Indonesia, Papua New Guinea, the Solomon Islands, and Vanuatu.
Malaria elimination has already been achieved in most of Europe, North America, Australasia, North Africa and the Caribbean, and parts of South America, Asia and Southern Africa, according to the Malaria Elimination Group at UCSF. The WHO defines elimination as having no domestic transmission for the past three years. They also define an "elimination stage" when a country is on the verge of eliminating malaria, as being <1 case per 1000 people at risk per year. According to the 2011 WHO World Malaria Report, 28 countries are certified as having eliminated malaria. Eight countries appear to be malaria free but steps still need to be taken to ensure they do not re-establish transmission. Nine countries are in the elimination stage and eight the pre-elimination stage (<5 cases per 1000 people at risk per year). The WHO also reports in 2010 malaria killed approximately 655,000 people—a reduction of approximately 36,000 from 2009.
At the Gates Foundation Malaria Forum in October 2007, Bill and Melinda Gates called for a new plan for malaria eradication, by going as far as possible with existing tools while also investing in new ones. Nearly a year later, on September 25, 2008, the Roll Back Malaria (RBM) Partnership unveiled the Global Malaria Action Plan (GMAP), in which a series of measures were proposed to eliminate malaria as a global public health concern by 2015, eliminate all malaria transmission within 8–10 countries by the same deadline, and build towards its eventual global eradication. The Malaria Policy Advisory Committee (MPAC) of the World Health Organization (WHO) was formed in 2012, "to provide strategic advice and technical input to WHO on all aspects of malaria control and elimination". In November 2013, WHO and the malaria vaccine funders group set a goal to develop vaccines designed to interrupt malaria transmission with the long-term goal of malaria eradication.
Regional elimination established or under way
Some diseases have already been eliminated from large regions of the world, and/or are currently being targeted for regional elimination. This is sometimes described as "eradication", although technically the term only applies when this is achieved on a global scale. Even after regional elimination is successful, interventions often need to continue to prevent a disease becoming re-established. Three of the diseases here listed (lymphatic filariasis, measles, and rubella) are among the diseases believed to be potentially eradicable by the International Task Force for Disease Eradication, and if successful, regional elimination programs may yet prove a stepping stone to later global eradication programs.
This section does not cover elimination where it is used to mean control programs sufficiently tight to reduce the burden of an infectious disease or other health problem to a level where they may be deemed to have little impact on public health, such as the leprosy, neonatal tetanus, or obstetric fistula campaigns.
In North American countries, such as the United States, elimination of hookworm had been attained due to scientific advances. The Rockefeller Foundation's hookworm campaign in the 1920s was supposed to focus on the eradication of hookworm infections for those living in Mexico and other rural areas. However, the campaign was politically influenced, causing it to be less successful, and regions such as Mexico still deal with these infections from parasitic worms. This use of health campaigns by political leaders for political and economic advantages has been termed the science-politics paradox.
Lymphatic filariasis is an infection of the lymph system by mosquito-borne microfilarial worms which can cause elephantiasis. Studies have demonstrated that transmission of the infection can be broken when a single dose of combined oral medicines is consistently maintained annually for approximately seven years. The strategy for eliminating transmission of lymphatic filariasis is mass distribution of medicines that kill the microfilariae and stop transmission of the parasite by mosquitoes in endemic communities. In sub-Saharan Africa, albendazole is being used with ivermectin to treat the disease, whereas elsewhere in the world albendazole is used with diethylcarbamazine. Using a combination of treatments better reduces the number of microfilariae in blood. Avoiding mosquito bites, such as by using insecticide-treated mosquito bed nets, also reduces the transmission of lymphatic filariasis. In the Americas, >90% of the burden of lymphatic filariasis is on the island of Hispaniola (comprising Haiti and the Dominican Republic). An elimination effort to address this is currently under way alongside the malaria effort described above; the Dominican Republic expects to eliminate its seven remaining foci by 2010, but lymphatic filariasis is still endemic to 110 of 140 communes in Haiti.
As of October 2008, the efforts of the Global Programme to Eliminate LF are estimated to have already prevented 6.6 million new filariasis cases from developing in children, and to have stopped the progression of the disease in another 9.5 million people who have already contracted it. Overall, of 83 endemic countries, mass treatment has been rolled out in 48, and elimination of transmission reportedly achieved in 21.
Five out of six WHO regions have goals to eliminate measles, and at the 63rd World Health Assembly in May 2010, delegates agreed to move towards eventual eradication, although no specific global target date has yet been agreed. The Americas set a goal in 1994 to eliminate measles and rubella transmission by 2000, and successfully achieved regional measles elimination in 2002, although there have been occasional small outbreaks from imported cases since then. Europe had set a goal to eliminate measles transmission by 2010, but were hindered by the MMR vaccine controversy and by low uptake in certain groups, and despite achieving low levels by 2008, European countries have since experienced a small resurgence in cases. They have set a new target of 2015. The Eastern Mediterranean also had goals to eliminate measles by 2010 (later revised to 2015), the Western Pacific aims to eliminate the disease by 2012, and in 2009 the regional committee for Africa agreed a goal of measles elimination by 2020. As of May 2010, only the South-East Asian region has yet to set a target date for elimination of measles transmission.
In 2005, a global target was agreed for a 90% reduction in measles deaths by 2010 from the 757,000 deaths in 2000; estimates for 2008 show a 78% decline so far to 164,000 deaths. However, some have been pushing to attempt global eradication. This was updated at the 2010 World Health Assembly to a targeted 95% reduction in mortality by 2015, alongside specific vaccination and structural targets, and in a meeting in November 2010, the Strategic Advisory Group of Experts on Immunization "concluded that measles can and should be eradicated". A study of the costs of eradicating measles compared to the costs of maintaining indefinite control was commissioned in 2009 by the WHO and the Bill and Melinda Gates Foundation. In 2013, measles deaths globally were down to 145,700.
As of mid 2013, measles elimination in many areas is stalling. "This year, measles and rubella outbreaks are occurring in many areas of the world where people have no immunity to these viruses. The reasons people are unvaccinated range from lack of access to vaccines in areas of insecurity, to poor performing health systems, to vaccine refusals. We need to address each of these challenges if we’re going to meet global measles and rubella elimination goals," said Dr. Myrna Charles of the American Red Cross, as reported in a post in the Measles and Rubella Initiative's blog. A look at the WHO’s epidemiological graph of measles over time from 2008-2013 show that, with little more of two years to go to 2015, measles cases in 2013 are moving in the wrong direction, with more cases this year than at the same point in 2012 or 2011.
Two WHO regions have set 2010 as a target for rubella elimination. The WHO region of the Americas set itself a target for regional elimination of rubella and congenital rubella syndrome by 2010. As of 2010, the last confirmed endemic case of rubella in the Americas was in Argentina in February 2009 and verification of regional elimination is currently under way and due to complete by 2012. The WHO European region also set a target of 2010. However, as of 2008 there were still 20,579 reported cases of rubella, 311 of which were laboratory confirmed, just among the 27 countries reporting data to EUVAC.
Onchocerciasis (river blindness) is the world's second leading cause of infectious blindness. It is caused by the nematode Onchocerca volvulus, which is transmitted to people via the bite of a black fly. Elimination of this disease is under way in the region of the Americas, where this disease is endemic to Brazil, Colombia, Ecuador, Guatemala, Mexico and Venezuela. The principal tool being used is mass ivermectin treatment. If successful, the only remaining endemic locations would be in Africa and Yemen. In Africa, it is estimated that greater than 102 million people in 19 countries are at high risk of onchocerciasis infection, and in 2008, 56.7 million people in 15 of these countries received community-directed treatment with ivermectin. Since adopting such treatment measures in 1997, the African Programme for Onchocerciasis Control reports a reduction in the prevalence of onchocerciasis in the countries under its mandate from a pre-intervention level of 46.5% in 1995 to 28.5% in 2008. Some African countries, such as Uganda, are also attempting elimination and successful elimination was reported in 2009 from two endemic foci in Mali and Senegal.
On July 29, 2013, the Pan American Health Organization (PAHO) announced that after 16 years of efforts, Colombia had become the first country in the world to eliminate the parasitic disease onchocerciasi.
Bovine spongiform encephalopathy (BSE) and new variant Creutzfeldt–Jakob disease (vCJD)
Following an epidemic of vCJD in the UK in the 1990s, there have been campaigns to eliminate BSE in cattle across the EU and beyond which appear to have achieved large reductions in the number of cattle with this disease. Cases of vCJD have also fallen since then, for instance from an annual peak in the UK of 28 cases in 2000 to five cases in 2011 and zero in 2012.
Other eradicable diseases
As far as animal diseases are concerned, now that rinderpest has been stamped out, many experts believe peste des petits ruminants (PPR) is the next disease amenable to global eradication. Also known as goat plague or ovine rinderpest, PPR is a highly contagious viral disease of goats and sheep characterized by fever, painful sores in the mouth, tongue and feet, diarrhoea, pneumonia and death, especially in young animals. It is caused by a virus of the genus Morbillivirus that is related to rinderpest, measles and canine distemper.
Futures and futuristic alien civilizations in which some or all infectious diseases have been eradicated are a staple of science fiction. Examples include:
The War of the Worlds by H. G. Wells, in which the Martians have long eradicated their own infectious diseases, leaving them vulnerable to Earth pathogens following the atrophy of their natural defences.
The Evitable Conflict, by Isaac Asimov, describes a future run by Machines in the manner which they see as most conducive to man's best interests, in which "we have eradicated the anopheles mosquito and the tsetse fly".
- Dowdle, Walter R (1998). "The Principles of Disease Elimination and Eradication". Bulletin of the World Health Organization 76 (S2): 22–25. PMID 10063669.
- Bartlett, M.S. (1957). "Measles periodicity and community size". J. Roy. Stat. Soc. Ser. A (120): 48–70.
- Dowdle, Walter; Cochi, Stephen L (editors) (2011). Disease Eradication in the 21st Century. Implications for Global Health. The MIT Press, Cambridge, MA
- Rinaldi A (2009). "Free at last! The progress of new disease eradication campaigns for Guinea worm disease and polio, and the prospect of tackling other diseases". EMBO reports 10 (3): 215–221. doi:10.1038/embor.2009.19. PMID 19255577.
- "Diseases considered as candidates for global eradication by the International Task Force for Disease Eradication". Cartercenter.org. Retrieved 2011-03-16.
- Fenner, F; Henderson, D A; Arita, I; Jezek, Z; Ladnyi, I D (1988). Smallpox and its Eradication. Geneva: World Health Organization. ISBN 92-4-156110-6.
- Baxby, Derrick (1999). "Edward Jenner's Inquiry; a bicentenary analysis". Vaccine 14 (4): 301–7. doi:10.1016/s0264-410x(98)00207-2. PMID 9987167.
- Dennis Normile (2008). "Driven to Extinction". Science 319 (5870): 1606–1609. doi:10.1126/science.319.5870.1606. PMID 18356500. Retrieved 2009-03-28.
- "UN 'confident' disease has been wiped out". BBC. 14 October 2010. Retrieved 14 October 2010.
- Due to the large increase in the number of vaccinators and field workers since 1998, the number of estimated cases is thought to be reasonably close to the actual reported number of cases in recent years. Aylward, Bruce, Jennifer Linkins. "Polio Eradication:mobilizing and managing the human resources". World Health Organization. Retrieved 2007-02-01.
- Mastny, Lisa (January 25, 1999). "Eradicating Polio: A Model for International Cooperation". Worldwatch Institute. Retrieved 2007-02-02.
- "PolioPlus Milestones". Rotary International. Retrieved 2007-02-22.
- "Wild Poliovirus Weekly Update". Global Polio Eradication Initiative. Retrieved 2010-03-17.
- "WHO Vaccine Preventable Diseases: Monitoring system" (PDF). World Health Organization. 2006. Retrieved 2007-02-02.
- Lee, Jong Wook (1995). "Ending polio - now or never?". The Progress of Nations. Unicef. Retrieved 2007-02-02.
- "Wild Poliovirus 2008 - 2013". Global Polio Eradication Initiative. Retrieved 2013-02-09.
- World Health Organization (2003). Global polio eradication initiative : strategic plan 2004-2008. Geneva: WHO. ISBN 92-4-159117-X. Retrieved 2007-11-30.
- "WHO South-East Asia Region certified polio-free". WHO. 27 March 2014. Retrieved 27 March 2014.
- "Progress towards interruption of wild poliovirus transmission—Worldwide, January 2007 to April 2008". MMWR Morb Mortal Wkly Rep 57 (18): 489–494. 2008. PMID 18472451. Retrieved 2009-01-16.
- Cochi and Kew; Kew, O (2008). "Polio today: are we on the verge of polio eradication?". JAMA 300 (7): 839–41. doi:10.1001/jama.300.7.839. PMID 18714066. Retrieved 2009-01-16.
- Kounteya Sinha (26 February 2012). "WHO takes India off polio list". The Times of India. Retrieved 1 March 2012.
- "India records one year without polio cases" (Press release). World Health Organization. 12 January 2012. Retrieved March 1, 2012.
- WHO. "Dracunculiasis Epidemiological Data (1989-2008)". World Health Organization. Retrieved 2009-09-14.
- WHO. "WHO Weekly Epidemiology Record 86, issue 10". Retrieved 2011-03-04.
- Carter Center. "Guinea Worm Wrap up 209".
- "Guinea Worm Disease: Case Countdown". Carter Center.
- Increase in reported cases resulted from improved reporting in southern Sudan following the peace agreement in 2005 "Progress Toward Global Eradication of Dracunculiasis, January 2005--May 2007 [sic]". MMWR Morb Mortal Wkly Rep 56 (32): 813–817. 2007. Retrieved 2011-03-16.
- Berry, Michele (June 21, 2007). "The Tail End of Guinea Worm — Global Eradication without a Drug or a Vaccine". The New England Journal of Medicine 356 (25): 2561–64. doi:10.1056/NEJMp078089. PMID 17582064.
- World Health Organisation. "Weekly Epidemiology Record 85, no 19, p. 166: Dracunculiasis eradication — global surveillance summary, 2009". World Health Organization. Retrieved 2010-05-14.
- Maurice, John (2012). "WHO plans new yaws eradication campaign". The Lancet 379: 1377–78. doi:10.1016/S0140-6736(12)60581-9.
- Rinaldi A (2012). "Yaws eradication: facing old problems, raising new hopes.". PLoS Neglected Tropical Diseases 6 (11): e18372. doi:10.1371/journal.pntd.0001837. PMID 23209846. Retrieved 2013-03-18.
- Asiedu et al.; Amouzou, B; Dhariwal, A; Karam, M; Lobo, D; Patnaik, S; Meheus, A (2008). "Yaws eradication: past efforts and future perspectives". Bulletin of the World Health Organization 86 (7): 499–500. doi:10.2471/BLT.08.055608. PMC 2647478. PMID 18670655. Retrieved 2009-04-02.
- "WHO South-East Asia report of an intercountry workshop on Yaws eradication". 2006.
- Drug and a syphilis test offer hope of yaws eradication, Thomas Reuter Foundation, accessed May 10, 2013
- Yaws Fact sheet N°316, World Health Organization, October 2012
- "Malaria Elimination Group description and list of elimination countries". Retrieved 2011-07-12.
- "WHO World Malaria Report 2011".
- Roberts and Enserink; Enserink, M. (7 December 2007). "MALARIA: Did They Really Say ... Eradication?". Science 318 (5856): 1544–1545. doi:10.1126/science.318.5856.1544. PMID 18063766.
- "Announcements — Bill & Melinda Gates Foundation".
- "Global Malaria Action Plan". Rollbackmalaria.org. Retrieved 2009-02-27.
- "Executive summary and key points". World Malaria Report 2013. World Health Organization. Retrieved 13 February 2014.
- "World Malaria Report 2013". World Health Organization. Retrieved 13 February 2014.
- "International task force for disease eradication program definitions". Retrieved 2010-07-11
- Birn Anne-Emanuelle, Solórzano Armando (1999). "Public health policy paradoxes: science and politics in the Rockefeller Foundation's hookworm campaign in Mexico in the 1920s". Social Science & Medicine 49 (9): 1197–1213. doi:10.1016/s0277-9536(99)00160-4. PMID 10501641.
- The Carter Center. "How is Lymphatic Filariasis Treated?". Archived from the original on 2008-04-14. Retrieved 2008-07-17.
- "Lymphatic Filariasis Disease — Carter Center Lymphatic Filariasis Program". Cartercenter.org. Retrieved 2009-02-27.
- U.S. Centers for Disease Control and Prevention. "Lymphatic filariasis prevention". Retrieved 2010-07-08
- "WHO Weekly Epidemiology Record 84 (11 & 12), 2009". who.int. Retrieved 2009-03-12.
- BBC World Service (2008-10-08). "'End in sight' for elephantiasis". BBC News. Retrieved 2008-10-08.
- "Sixty-third World Health Assembly Agenda provisional agenda item 11.15 Global eradication of measles". Retrieved 2 June 2010.
- "Sixty-third World Health Assembly notes from day four". Retrieved 2 June 2010.
- "State of the world's vaccines and immunization. Third edition". World Health Organization. 2009-11-24. Retrieved 2 February 2010.
- "CDC MMWR, progress towards measles elimination". 2004.
- "Global measles and rubella strategic plan : 2012-2020". World Health Organization. Retrieved 5 May 2013.
- WHO Weekly Epidemiology Record 84 (49), 4th December 2009 http://www.who.int/wer/2009/wer8449/en/index.html
- de Quadros (2004). "Can measles be eradicated globally?". Bulletin of the World Health Organization (82(2)). doi:10.1590/S0042-96862004000200011. Retrieved 2009-11-15.
- "WHO Weekly Epidemiology Record 86, issues 1-2: Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 – summary, conclusions and recommendations".
- WHO Weekly Epidemiology Record 84(44), Meeting of the International Task Force for Disease Eradication, June 2009, pages 459-465 http://www.who.int/wer/2009/wer8444.pdf
- Measles Fact sheet N°286, World Health Organization, November 2014
- "Mid-Year 2013: Measles and Rubella So Far". Retrieved 25 September 2013.
- "Measles Case Distribution by Month and WHO Regions, 2008-2013". Retrieved 25 September 2013.
- "January–February 2010 Rubella Watch". Retrieved 2010-07-11.
- "March–April 2010 Rubella Watch". Retrieved 2010-07-11.
- "Eliminating measles and rubella and preventing congenital rubella infection WHO European Region Strategic Plan 2005-2010". Retrieved 2010-07-11.
- "EUVAC.net rubella surveillance report 2008". Retrieved 2010-07-11.
- "WHO Weekly Epidemiology Record" (83(29)). 2008
- "WHO Weekly Epidemiology Record" (85(04)). 2010
- The Carter Center (2008-01-22). "Uganda Attempts Nationwide Elimination of River Blindness". Cartercenter.org. Retrieved 2009-02-27.
- Lamine Diawara, Mamadou O. Traoré, Alioune Badji1, Yiriba Bissan, Konimba Doumbia, Soula F. Goita, Lassana Konaté, Kalifa Mounkoro, Moussa D. Sarr, Amadou F. Seck, Laurent Toé, Seyni Tourée, Jan H. F. Remme (2009). Basáñez, María-Gloria, ed. "Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal". PLoS Negl Trop Dis 3 (3(7): e497.): e497. doi:10.1371/journal.pntd.0000497.
- "NEWS SCAN: Columbia ousts river blindness; Vaccine-derived polio in India; Danish Salmonella trends". CIDRAP News. July 30, 2013.
- "Frequently asked questions about BSE". Retrieved 2011-03-16.
- "Creutzfeldt-Jakob disease in the UK". The National CJD Research and Surveillance Unit, University of Edinburgh. 2013-03-04. Retrieved 2013-03-13.
- Rinaldi A (2013). "Tackling animal diseases to protect human health. As veterinary science celebrates cattle plague eradication, the inextricable link between human, animal and ecosystem health is increasingly appreciated.". EMBO reports 14 (1): 31–35. doi:10.1038/embor.2012.201. PMID 23229587.